Karolina Weiner‐Gorzel
Publications by Year
Research Areas
MicroRNA in disease regulation, Extracellular vesicles in disease, Histone Deacetylase Inhibitors Research, Nanoplatforms for cancer theranostics, Peptidase Inhibition and Analysis
Most-Cited Works
- → The fate of chemoresistance in triple negative breast cancer (TNBC)(2015)377 cited
- → Overexpression of the microRNA miR‐433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells(2015)160 cited
- → Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells(2017)104 cited
- → Mitochondrial dynamics, a new therapeutic target for Triple Negative Breast Cancer(2021)59 cited
- → HDAC6 Degradation Inhibits the Growth of High-Grade Serous Ovarian Cancer Cells(2020)40 cited
- → The impact of TSG101 in triple-negative breast cancers.(2014)3 cited
- → Low nuclear MAD2 expression is associated with of lack of response to chemotherapy and radiotherapy in oestrogen receptor negative breast cancer patients(2013)2 cited
- → Abstract A34: MiR-433 induces cellular senescence rendering ovarian cancer cells less likely to undergo chemotherapy-induced apoptosis(2015)1 cited
- → Abstract B56: Transfer of senescent signals in a hypoxic tumor microenvironment: A mechanism of tumor cell survival mediated by exosomes(2015)
- Resistance to chemotherapy in ovarian cancer is miRrored by the microRNA miR-433-dependent dysregulation of the cell cycle.(2015)